These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [Seroepidemiology studies on population immune background to viral hepatitis B].
    Author: Duca E, Romaniuc A, Trifan M, Butur D, Ivan A.
    Journal: Rev Med Chir Soc Med Nat Iasi; 2007; 111(2):494-9. PubMed ID: 17983191.
    Abstract:
    MATERIAL AND METHOD: The studies have been carried out in 855 males and females aged over 20 years belonging to the general population and health care profession included in the European Sero-Epidemiology Network (ESEN) Programme aimed at assessing the population immune background against hepatitis B virus. The serological markers, represented by HBsAg, antibodies to HBsAg (anti-HBsAg) and HBcAg (anti-HBcAg) were investigated by the methods widely used in seroepidemiology studies. The patients were divided into 4 subgroups. RESULTS: In the blood serum of a subgroup of 220 individuals, HBsAg was found in 33.2%, anti-HBs in 41.3%, and anti-HBc in 25.4%. In another subgroup of 219 individuals, significantly increased levels of the anti-HBs were recorded in 50.2%. In the subgroup of 168 individuals, IgG anti-HBc were present in 84.6% of those aged over 40 years who had acute HBV infection. In the subgroup of 248 healthcare professionals the prevalence of anti-HBs carriers was 50-80%, result of vaccine-prevention.
    [Abstract] [Full Text] [Related] [New Search]